TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(8 sites)

Spain

Complejo Hospitalario Universitario A Coruña, A Coruña

Hospital del Mar, Barcelona

Marqués de Valdecilla Research Institute, Santander

Hospital Universitario Dr. Peset, Valencia

Sweden

Skåne University Hospital, Malmo, Skåne County

Transplant Center, Sahlgrenska University Hospital, Gothenburg, Vastra Gotaland Regioin

Karolinksa University Hospital, Stockholm

Uppsala University Hospital, Uppsala